Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

CompletedPhase 3

Sponsor: UCB Biopharma SRL

Conditions: Generalized Myasthenia Gravis

Interventions: zilucoplan (RA101495)

Countries: United States, Canada, France, Germany, Italy, Japan, Norway, Poland

The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Completion of a qualifying zilucoplan study

Exclusion Criteria:

* With the exception of a prior zilucoplan trial, participation in another concurrent clinical trial involving an experimental therapeutic intervention (participation in observational studies and/or registry studies is permitted)
Locations (70)
  • Mobile, Alabama, United States
  • Phoenix, Arizona, United States
  • Irvine, California, United States
  • Los Angeles, California, United States
  • Pasadena, California, United States
  • San Francisco, California, United States
  • New Haven, Connecticut, United States
  • Washington D.C., District of Columbia, United States
  • Tampa, Florida, United States
  • Augusta, Georgia, United States
  • Glenview, Illinois, United States
  • Indianapolis, Indiana, United States
  • Kansas City, Kansas, United States
  • Detroit, Michigan, United States
  • East Lansing, Michigan, United States
  • Columbia, Missouri, United States
  • Las Vegas, Nevada, United States
  • Buffalo, New York, United States
  • Great Neck, New York, United States
  • New York, New York, United States
  • New York, New York, United States
  • Chapel Hill, North Carolina, United States
  • Cleveland, Ohio, United States
  • Columbus, Ohio, United States
  • Pittsburgh, Pennsylvania, United States
  • Charleston, South Carolina, United States
  • Cordova, Tennessee, United States
  • Austin, Texas, United States
  • Dallas, Texas, United States
  • Salt Lake City, Utah, United States
  • + 40 more on CT.gov